The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

Cigna (CI) and UnitedHealth (UNH) significantly marked up prices for specialty generic drugs over a six-year period.

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...